Stock Analysis

Alten S.A. (EPA:ATE) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

ENXTPA:ATE
Source: Shutterstock

Last week, you might have seen that Alten S.A. (EPA:ATE) released its full-year result to the market. The early response was not positive, with shares down 7.2% to €134 in the past week. It was an okay report, and revenues came in at €4.1b, approximately in line with analyst estimates leading up to the results announcement. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

See our latest analysis for Alten

earnings-and-revenue-growth
ENXTPA:ATE Earnings and Revenue Growth February 28th 2024

Taking into account the latest results, the consensus forecast from Alten's five analysts is for revenues of €4.29b in 2024. This reflects an okay 5.3% improvement in revenue compared to the last 12 months. Before this earnings report, the analysts had been forecasting revenues of €4.32b and earnings per share (EPS) of €8.52 in 2024. So we can see that while the consensus made no real change to its revenue estimates, it also no longer provides an earnings per share estimate. This suggests that revenues are what the market is focusing on after the latest results.

There's been no real change to the consensus price target of €159, with Alten seemingly executing in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Alten at €170 per share, while the most bearish prices it at €150. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Alten is an easy business to forecast or the the analysts are all using similar assumptions.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that Alten's revenue growth is expected to slow, with the forecast 5.3% annualised growth rate until the end of 2024 being well below the historical 13% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 6.6% per year. Factoring in the forecast slowdown in growth, it seems obvious that Alten is also expected to grow slower than other industry participants.

The Bottom Line

The clear take away from these updates is that the analysts made no change to their revenue estimates for next year, with the business apparently performing in line with their models. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

At least one of Alten's five analysts has provided estimates out to 2026, which can be seen for free on our platform here.

We don't want to rain on the parade too much, but we did also find 1 warning sign for Alten that you need to be mindful of.

Valuation is complex, but we're helping make it simple.

Find out whether Alten is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.